In HCC, upregulation of PVRL1 stabilizes the surface expression of PVR, which interacts with the inhibitory receptor TIGIT on CD8+ effector memory T cells, suppressing antitumor immune responses and leading to resistance to PD-1 inhibitors [109]. Here, PDCD1 is linked to hepatocellular carcinoma.